Spectra254, a developer of easy-to-use, affordable UVC light decontamination systems, has released a recent study by Johns Hopkins Medicine that reports that Spectra254’s Spectra 1000 Series of UV light decontamination system is highly effective in killing three major healthcare-acquired pathogens recently named by the Centers for Disease Control and Prevention (CDC) as urgent or serious public health threats.
The Department of Hospital Epidemiology and Infection Control at Johns Hopkins Medicine in Baltimore conducted the 2014 study on the Spectra 1000 Series. The device was tested in an unoccupied, fully furnished intensive care hospital room and bathroom. The conclusion from the testing is that the Spectra 1000 Series delivers so much UV energy that it has the potential to kill pathogens directly and indirectly exposed to the UVC light.
“The Johns Hopkins study of the Spectra 1000 Series of UV light decontamination systems clearly demonstrates the effectiveness of these systems,” says Sanford Green, Spectra254 president. “Using a Spectra254 system can literally save lives, and reduce costs for medical care facilities and consumers in very concrete ways.”
To conduct the study, Johns Hopkins Medicine infected Formica sheets with MRSA, VRE and CRE. The inoculated plates were placed on horizontal surfaces or taped to vertical surfaces in direct line of UV light such as bed rails, top of tray table, top of chair arm, top of telephone, top of call bell, door of cabinet and in shaded areas such as the far side of the bedside table facing the wall, side of the chair facing the wall, back of the head of the bed, and placed 5 and 10 feet from the Spectra 1000 Series. After exposure, the Spectra 1000 Series killed the pathogens in both the directly exposed surfaces and those that were in partially shaded locations, including shaded sites, such as under the bed.
Spectra254’s product line of portable ultraviolet light-generating systems is ideal for use in hospitals, health clinics, food preparation areas and other settings where contamination is of critical concern. The Spectra 1000 Series of UV light decontamination system features high-intensity, custom-made lamps that broadcast a high output of UVC light to virtually every surface in the area being treated to kill pathogens such as C. difficile, MRSA, HIV, norovirus and salmonella. Spectra254 manufactures mobile systems that can decontaminate a space within 5 minutes, and provides a “green” supplement to the typical use of harsh chemicals. The company’s systems are manufactured and assembled in a U.S.-based ISO 9000 facility that meets or exceeds the quality assurance standards outlined by International Organization of Standards.
Source: Spectra254
The Evolution of Health Care Environmental Hygiene: A Long Overdue Shift in Infection Control
September 5th 2024This new column, Clean Hospital with Alexandra Peters, PhD, explores advancements in health care environmental hygiene, highlighting its growing recognition as a key component of infection prevention and honoring pioneers like Professor Stephanie Dancer.
New UV-C Disinfection Technology for Ultrasound Probes Earns FDA Clearance
September 4th 2024Chronos, a chemical-free UV-C disinfection device for ultrasound probes, received FDA clearance. It offers health care professionals a fast, automated solution to reduce cross-contamination and improve infection prevention.
Infection Intel: Augmenting SHIELD WALL Modular Containment Systems by Abatement Technologies
August 8th 2024Jackie Otero, senior territory sales representative at Abatement Technologies, discusses the SHIELD WALL modular containment system by Abatement Technologies, highlighting its quick assembly, durability, noise reduction, and benefits in maintaining indoor air quality in health care settings.
Phage Therapy: The Future of Bacterial Infection Treatment?
August 7th 2024Rising antibiotic resistance necessitates exploring phage therapy as an alternative. Despite historical sidelining, phages show promise in treating various infections, but regulatory, safety, and resistance challenges remain.